US-based Biotech PE fund 108 Bio Capital backs Ciraparantag maker Pinwheel Therapeutics, commits $20mn for Phase2b trial
Mike Bingle, Ranjan Pai, Suresh Vazirani, Gautam Daftary backed 108 BioCapital funds Ciraparantag maker Pinwheel Therapeutics, commits $20mn for Phase2b trial Connecticut-based Pinwheel Therapeutics Acquires Anticoagulant Reversal Agent, Ciraparantag, and Inaugural funding from 108 BioCapital….